Search Results
Apr 01, 2026, 08:50 ET Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing
www.cytovance.com), a leading full-service contract development and manufacturing organization ("CDMO") specializing in mammalian and microbially expressed biologics, to produce cGMP clinical materials for its planned Phase 2 clinical trial of its breast
More news about: Anixa Biosciences, Inc.
Apr 01, 2026, 07:35 ET Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration
Corporate and Financial HighlightsCDMO revenues doubled year-over-year to $1.3 million, reflecting continued commercial traction and execution of development and manufacturing programsExpanded CDMO platform post year-end through the acquisition of Recipharm Israel
More news about: Scinai Immunotherapeutics Ltd.
Mar 31, 2026, 19:00 ET NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development
patients."About NJ Bio, Inc.NJ Bio, Inc. is a leading Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) headquartered in Princeton, New Jersey, with additional chemistry facilities in Bristol, Pennsylvania and Mumbai, India. The company provides fully
More news about: Ajinomoto Bio-Pharma Services
Mar 31, 2026, 19:00 ET NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development
patients."About NJ Bio, Inc.NJ Bio, Inc. is a leading Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) headquartered in Princeton, New Jersey, with additional chemistry facilities in Bristol, Pennsylvania and Mumbai, India. The company provides fully
More news about: Ajinomoto Bio-Pharma Services
Mar 31, 2026, 10:00 ET Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland
March 31, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company's first manufacturing
More news about: Samsung Biologics
Mar 31, 2026, 10:00 ET Dalton Pharma Services Expands Aseptic Powder Fill-Finish Capacity with RoboFil™ system in Toronto
manufacturing."About Dalton Pharma Services: Dalton Pharma Services is a full-service Contract Development and Manufacturing Organization (CDMO) based in Toronto, Canada. With 37 years of proven performance, Dalton's single-site model integrates API development and cGMP manufacturing, formulation,
More news about: Dalton Pharma Services
Mar 31, 2026, 10:00 ET Dalton Pharma Services Expands Aseptic Powder Fill-Finish Capacity with RoboFil™ system in Toronto
manufacturing."About Dalton Pharma Services: Dalton Pharma Services is a full-service Contract Development and Manufacturing Organization (CDMO) based in Toronto, Canada. With 37 years of proven performance, Dalton's single-site model integrates API development and cGMP manufacturing, formulation,
More news about: Dalton Pharma Services
Mar 30, 2026, 11:01 ET Viva Biotech Announces 2025 Annual Results: AI-Driven Drug Discovery Reinforces Industry Leadership, CDMO Commercial Products Enter Rapid Scale-Up
First-in-Class drug discovery, focusing on new targets, novel mechanisms of action (MOA), and new modality.Successful Commercial Launch of New CDMO Projects, Sustained Improvement in CMC Business ProfitabilityThe Group is committed to building a global one-stop service platform covering
More news about: Viva Biotech
Mar 30, 2026, 10:01 ET Viva Biotech Announces 2025 Annual Results: AI-Driven Drug Discovery Reinforces Industry Leadership, CDMO Commercial Products Enter Rapid Scale-Up
First-in-Class drug discovery, focusing on new targets, novel mechanisms of action (MOA), and new modality.Successful Commercial Launch of New CDMO Projects, Sustained Improvement in CMC Business ProfitabilityThe Group is committed to building a global one-stop service platform covering
More news about: Viva Biotech
Mar 30, 2026, 10:01 ET PFAS Waste Management Market worth $2.98 billion in 2031 - Exclusive Report by MarketsandMarkets™
Electronic Chemicals CDMO & CRO Market - Global Forecast to 2029
More news about: MarketsandMarkets
Mar 30, 2026, 01:33 ET WuXi Biologics Honored with CDMO Leadership Awards for Ninth Consecutive Year
Manufacturing Organization (CRDMO), announced that it has won "Biologics CDMO of the Year" (Large CDMOs) in the 2026 CDMO Leadership Awards. The company has also been recognized for excellence across multiple categories for "Large CDMO Biologic", including "Best Scaling Support", "Best Analytical Services",
More news about: WuXi Biologics
Mar 26, 2026, 21:29 ET Piramal Pharma Solutions celebra il 20° anniversario dello stabilimento di Morpeth con l'acquisizione della pressa per compresse Korsch X3
marzo 2026 /PRNewswire/ -- Piramal Pharma Solutions, organizzazione leader a livello mondiale nello sviluppo e nella produzione a contratto (CDMO) e parte di Piramal Pharma Ltd (NSE: PPLPHARMA) (BSE: 543635), è orgogliosa di annunciare l'installazione di una pressa per compresse ad alto contenimento
More news about: Piramal Pharma Solutions
Mar 26, 2026, 15:46 ET Piramal Pharma Solutions commémore le 20e anniversaire de son site de Morpeth en achetant une presse à comprimés Korsch X3
26 mars 2026 /PRNewswire/ -- Piramal Pharma Solutions, une organisation de développement et de fabrication sous contrat (CDMO) mondiale de premier plan, qui fait partie de Piramal Pharma Ltd. (NSE : PPLPHARMA) (BSE : 543635), est fière d'annoncer l'installation d'une
More news about: Piramal Pharma Solutions
Mar 26, 2026, 14:40 ET Piramal Pharma Solutions conmemora el 20º aniversario de su planta de Morpeth
26 de marzo de 2026 /PRNewswire/ -- Piramal Pharma Solutions, una organización líder mundial en desarrollo y fabricación por contrato (CDMO) y parte de Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), se complace en anunciar la instalación de una prensa de comprimidos de alta contención
More news about: Piramal Pharma Solutions
Mar 26, 2026, 12:54 ET Piramal Pharma Solutions feiert das 20-jährige Jubiläum seines Standorts in Morpeth mit der Anschaffung einer Korsch X3-Tablettenpresse
26. März 2026 /PRNewswire/ -- Piramal Pharma Solutions, ein weltweit führendes Auftragsentwicklungs- und Produktionsunternehmen (CDMO) und Teil der Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), gibt stolz die Installation einer Korsch X3-Tablettenpresse mit hoher Sicherheitsstufe
More news about: Piramal Pharma Solutions
Mar 26, 2026, 09:05 ET Made Scientific and New Jersey Institute of Technology Announce Partnership to Enhance Graduate-Level Cell and Gene Therapy Bioprocessing Curriculum
organization (CDMO) specializing in the development, manufacturing, and release of autologous and allogeneic cell therapy products for clinical and commercial supply. Headquartered in Princeton, New Jersey, Made Scientific combines the agility and entrepreneurial spirit of a specialist CDMO with deep technical
More news about: Made Scientific, Inc.
Mar 26, 2026, 08:00 ET Samsung Biologics Recognized for Advancing Sustainability at 2026 CDMO Leadership Awards
26, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), received recognition at the 2026 CDMO Leadership Awards presented by Outsourced Pharma and Life Science Connect. The company was awarded the Sustainability Leadership
More news about: Samsung Biologics
Mar 26, 2026, 08:00 ET TopGum Reports Record Year: Revenue Surpasses $100 Million Milestone with ~70% Growth; Adjusted EBITDA Climbs ~65%; Operating Income Surges ~126%
We enter 2026 with strong demand, advanced production infrastructure, and a reinforced competitive position, on our path to becoming a leading global CDMO for healthcare products, built on advanced, enjoyable delivery systems. I would like to thank the Company's employees and Board of Directors for their
More news about: TopGum Industries Ltd.
Mar 26, 2026, 06:00 ET Innovent Announces 2025 Annual Results and Business Updates
Site 1 houses 60,000 liters of antibody capacity and ADC commercial lines; Site 2 has 80,000 liters of antibody capacity, supporting global supply and CDMO services.Sustainable Development and ESG Commitment8,000 employees worldwide, with global R&D centers
More news about: Innovent Biologics
Mar 25, 2026, 14:55 ET Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
March 25, 2026 /PRNewswire/ -- Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), is proud to announce the installation of a Korsch X3 high containment tablet
More news about: Piramal Pharma Solutions
Mar 25, 2026, 14:53 ET Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
March 25, 2026 /PRNewswire/ -- Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), is proud to announce the installation of a Korsch X3 high containment tablet
More news about: Piramal Pharma Solutions
Mar 24, 2026, 05:16 ET /C O R R E C T I O N -- Kindeva/
March 24, 2026 /PRNewswire/ -- Kindeva, a global CDMO and drug delivery innovator, commemorates 70 years today, since the invention of the pressurized metered dose inhaler (pMDI), a breakthrough therapy
More news about: Kindeva
Mar 23, 2026, 09:15 ET WuXi XDC Delivers Exceptional Performance in 2025, Reinforcing Global Leadership in Bioconjugate CRDMO
backlog grew to US$1.49 billion, representing a strong 50.3% YoY growthWinner of "Best CDMO" and "Best CRO" Awards: Three consecutive "Best CDMO" Awards from 2023 to 2025 at World ADC Awards, and "Best CRO" Awards at 2025 World ADC AwardsSHANGHAI,
More news about: WuXi XDC
Mar 23, 2026, 08:40 ET Cambrex avanza las expansiones en EE. UU. y Europa
23 de marzo de 2026 /PRNewswire/ -- Cambrex, una organización líder mundial de desarrollo y fabricación por contrato (CDMO, por sus siglas en inglés), anunció hoy la finalización de los estudios iniciales de ingeniería para su nueva planta de fabricación de ingredientes
More news about: Cambrex
Mar 23, 2026, 08:00 ET Cambrex 推動美國和歐洲擴張
新澤西州東盧瑟福2026年3月23日 /美通社/ -- 全球領先的合約研究開發與製造組織 (CDMO) Cambrex，於今天宣佈已完成其位於愛荷華州查爾斯城的嶄新大型活性藥物成分 (API) 生產工廠的初步工程研究。 這項里程碑標誌著該公司取得了重大進展，穩步實踐先前宣佈擴大其美國活性藥物成分產能的 1.2 億美元投資計劃。 新設施的動土儀式計劃於 2026 年底舉行。
More news about: Cambrex